Point72 Asset Management, L.P. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-04 5:13 pm Purchase | 2025-08-27 | 13G | Pliant Therapeutics, Inc. PLRX | Point72 Asset Management, L.P. | 4,085,017 6.700% | 4,085,017 (New Position) | Filing |